A scleroderma-like cutaneous syndrome associated with a marked th2-type immune response occurring after a prosthetic joint implant

Journal of Clinical Rheumatology

Volumn 15, Issue 3, 2009, Pages 133-137

  Romano, Ciro ^a   Sellitto, Ausilia ^a   De Fanis, Umberto ^a   Rossiello, Raffaele ^b   Rossiello, Luigi ^a   Giunta, Riccardo ^a   Lucivero, Giacomo ^a  

^a Allergy and Clinical Immunology   (Italy)

^b SECOND UNIVERSITY OF NAPLES   (Italy)

Author keywords

IL 13; IL 4, IL 5; Prosthetic joint; Scleroderma like cutaneous syndrome; Th2 cells; Th2 cytokines

Indexed keywords

ANTIBIOTIC AGENT; DEFLAZACORT; IMMUNOGLOBULIN E; INTERLEUKIN 13; INTERLEUKIN 4; INTERLEUKIN 5; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; NONSTEROID ANTIINFLAMMATORY AGENT; COBALT; CYTOKINE; DRUG DERIVATIVE; IMMUNOSUPPRESSIVE AGENT; MYCOPHENOLIC ACID; PREGNANE DERIVATIVE;

AGED; ARTICLE; BACTERIUM CULTURE; BLOOD ANALYSIS; CAPILLAROSCOPY; CASE REPORT; CELLULAR IMMUNITY; COMPUTER ASSISTED TOMOGRAPHY; DISEASE ASSOCIATION; DRUG SUBSTITUTION; DRUG WITHDRAWAL; ECHOCARDIOGRAPHY; FEMALE; HOSPITAL ADMISSION; HUMAN; KNEE PROSTHESIS; LABORATORY TEST; MUSCLE BIOPSY; PATHOGENESIS; PRIORITY JOURNAL; SCLERODERMA; SKIN BIOPSY; SKIN FIBROSIS; SPIROMETRY; T LYMPHOCYTE; TH2 CELL; THORAX RADIOGRAPHY; UNSPECIFIED SIDE EFFECT; BLOOD; EOSINOPHILIA; ERYTHEMA; IMMUNOLOGY; KNEE ARTHROPLASTY; LIMITED SCLERODERMA; PATHOLOGY; SYNDROME;

AGED; ARTHROPLASTY, REPLACEMENT, KNEE; COBALT; CYTOKINES; EOSINOPHILIA; ERYTHEMA; FEMALE; HUMANS; IMMUNOGLOBULIN E; IMMUNOSUPPRESSIVE AGENTS; KNEE PROSTHESIS; MYCOPHENOLIC ACID; PREGNENEDIONES; SCLERODERMA, LIMITED; SYNDROME;

EID: 67649713469     PISSN: 10761608     EISSN: None     Source Type: Journal    
DOI: 10.1097/RHU.0b013e31819e6798     Document Type: Article

References (12)

1. Mori Y, Kahari V-M, Varga J. Scleroderma-like cutaneous syndromes. Curr Rheum Rep. 2002;4:113-122.
2. Seibold JR. Scleroderma. In: Harris ED, Budd RC, Firestein GS, et al, eds. Kelley's Textbook of Rheumatology. 7th ed. Philadelphia, PA: Elsevier Saunders; 2005:1279-1308.
3. Marzano AV, Menni S, Parodi A, et al. Localized scleroderma in adults and children. Clinical and laboratory investigations on 239 cases. Eur J Dermatol. 2003;13:171-176.
4. Misumi M, Ideguchi H, Tuji T, et al. Case of eosinophilic fasciitis with change of serum Th 1/Th 2 cytokine level which correlated with disease activity. Nihon Rinsho Meneki Gakkai Kaishi. 2002;25:263-269.
5. Shakoory B, Fitzgerald SM, Lee SA, et al. The role of human mast cell-derived cytokines in eosinophil biology. J Interferon Cytokine Res. 2004;24: 271-281.
6. Laing TJ, Schottenfeld D, Lacey JV, et al. Potential risk factors for undif-ferentiated connective tissue disease among women: implanted medical devices. Am J Epidemiol. 2001;154:610-617.
7. Granchi D, Cenni E, Trisolino G, et al. Sensitivity to implant materials in patients undergoing total hip replacement. J Biomed Mater Res B Appl Biomater. 2006;77:257-264.
8. Merritt K, Rodrigo JJ. Immune response to synthetic materials. Sensitization of patients receiving orthopaedic implants. Clin Orthop Relat Res. 1996;326: 71-79.
9. Fallon PG, Richardson EJ, McKenzie GJ, et al. Schistosome infection of transgenic mice defines distinct and contrasting pathogenic roles for IL-4 and IL-13: IL-13 is a profibrotic agent. J Immunol. 2000;164:2585-2591.
10. Kolodsick JE, Toews GB, Jakubzick C, et al. Protection from fluorescein isothiocyanate-induced fibrosis in IL-13-deficient, but not IL-4-deficient, mice results from impaired collagen synthesis by fibroblasts. J Immunol. 2004;172:4068-4076.
11. Varga J, Kahari VM. Eosinophilia-myalgia syndrome, eosinophilic fasciitis, and related fibrosing disorders. Curr Opin Rheumatol. 1997;9:562-570.
12. Rothenberg ME, Hogan SP. The eosinophil. Annu Rev Immunol. 2006;24: 147-174.